Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.
Members of the pentraxin family, including PTX3 and serum amyloid P component (SAP), have been reported to play a role in innate host defence against a range of microbial pathogens, yet little is known regarding their antiviral activities. In this study, we demonstrate that human SAP binds to human...
Guardado en:
Autores principales: | Emma R Job, Barbara Bottazzi, Brad Gilbertson, Kathryn M Edenborough, Lorena E Brown, Alberto Mantovani, Andrew G Brooks, Patrick C Reading |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f07531ab19844848008cdb5ee48adb6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of a novel method to evaluate sialylation of glycoproteins and analysis of gp96 sialylation in Hela, SW1990 and A549 cell lines
por: Liang,Yangui, et al.
Publicado: (2015) -
MARCH8 Restricts Influenza A Virus Infectivity but Does Not Downregulate Viral Glycoprotein Expression at the Surface of Infected Cells
por: Fernando Villalón-Letelier, et al.
Publicado: (2021) -
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis
por: Yuhsuke Ohmi, et al.
Publicado: (2016) -
Variability of serum IgG sialylation and galactosylation degree in women with advanced endometriosis
por: Katarzyna Sołkiewicz, et al.
Publicado: (2021) -
Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus
por: Andrea Doni, et al.
Publicado: (2021)